DING Jiru,ZHANG Huan,LIU Dongmin,et al.Gegen Qinliantang Ameliorates Glucose and Lipid Metabolism Disorders in Rat Model of Catch-up Growth by Regulating SIRT1/PGC1α/Nrf1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):77-86.
DING Jiru,ZHANG Huan,LIU Dongmin,et al.Gegen Qinliantang Ameliorates Glucose and Lipid Metabolism Disorders in Rat Model of Catch-up Growth by Regulating SIRT1/PGC1α/Nrf1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):77-86. DOI: 10.13422/j.cnki.syfjx.20231836.
Gegen Qinliantang Ameliorates Glucose and Lipid Metabolism Disorders in Rat Model of Catch-up Growth by Regulating SIRT1/PGC1α/Nrf1 Signaling Pathway
Gegen Qinliantang and Its Modified Prescriptions Ameliorate Insulin Resistance in Type 2 Diabetes Mellitus: A Review
Effect of Gegen Qinliantang on SIRT1/FoxO1 Autophagy Pathway in db/db Diabetic Mice
Salvianolic Acid B Improves Glucose and Lipid Metabolism and Insulin Resistance in Rat Models with Type 2 Diabetes
Analysis of Potential Active Ingredients and Mechanism of Baihu Jia Renshentang in Treatment of Obesity Complicated with Type 2 Diabetes Mellitus
Related Author
LIU Yimin
JI Yanhua
CHEN Mengjie
YAN Xiaojun
LIU Hongning
ZENG Zhijun
ZHANG Yuanyuan
ZHU Xiangdong
Related Institution
Research Center for Differentiation and Development of Traditional Chinese Medicine(TCM) Basic Theory, Jiangxi Province Key Laboratory of TCM Etiopathogenisis, Jiangxi University of Chinese Medicine
Gansu Key Laboratory for Excavation,Innovation,and Transformation of Traditional Chinese Medicine,Diabetes Laboratory,Gansu University of Chinese Medicine
Ningxia Medical University
School of Traditional Chinese Medicine,Hunan University of Chinese Medicine